J. Vandyk et al., COMMISSIONING AND QUALITY ASSURANCE OF TREATMENT PLANNING COMPUTERS, International journal of radiation oncology, biology, physics, 26(2), 1993, pp. 261-273
Citations number
39
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
The process of radiation therapy is complex and involves many steps. A
t each step, comprehensive quality assurance procedures are required t
o ensure the safe and accurate delivery of a prescribed radiation dose
. This report deals with a comprehensive commissioning and ongoing qua
lity assurance program specifically for treatment planning computers.
Detailed guidelines are provided under the following topics: (a) compu
ter program and system documentation and user training, (b) sources of
uncertainties and suggested tolerances, (c) initial system checks, (d
) repeated system-checks, (e) quality assurance through manual procedu
res, and in vivo dosimetry, and (f) some additional considerations inc
luding administration and manpower requirements. In the context of com
mercial computerized treatment planning systems, uncertainty estimates
and achievable criteria of acceptability are presented for: (a) exter
nal photon beams, (b) electron beams, (c) brachytherapy, and (d) treat
ment machine setting calculations. Although these criteria of acceptab
ility appear large, they approach the limit achievable with most of to
day's treatment planning systems. However, developers of new or improv
ed dose calculation algorithms should strive for the goal recommended
by the International Commission of Radiation Units and Measurements of
2% in relative dose accuracy in low dose gradients or 2 mm spatial ac
curacy in regions with high dose gradients. For brachytherapy, the aim
should be 3% accuracy in dose at distances of 0.5 cm or more at any p
oint for any radiation source. Details are provided for initial commis
sioning tests and follow-up reproducibility tests. The final quality a
ssurance for each patient is to perform an independent manual check of
at least one point in the dose distributions, as well as the machine
setting calculation. As a check of the overall treatment planning proc
ess, in vivo dosimetry should be performed on a select number of patie
nts.